2010/07/30

SHIONOGI INC. ANNOUNCES FDA APPROVAL OF CUVPOSA FOR THE TREATMENT OF CHRONIC SEVERE DROOLING IN PEDIATRIC PATIENTS WITH NEUROLOGIC CONDITIONS